Drug Delivery with Targeted Nanoparticles
portes grátis
Drug Delivery with Targeted Nanoparticles
In Vitro and In Vivo Evaluation Methods
Capan, Yilmaz; Sahin, Adem; Tonbul, Hayrettin
Jenny Stanford Publishing
11/2021
762
Dura
Inglês
9789814877756
15 a 20 dias
1620
Descrição não disponível.
1. Particle Size Determination of Targeted Nanoparticles 2. Zeta Potential Determination of Targeted Nanoparticles 3. Stability of Targeted Nanoparticles 4. Impact of PEGylation on Targeted Nanoparticulate Delivery 5. Ligands and Receptors for Targeted Delivery of Nanoparticles: Recent Updates and Challenges 6. Characterization of Biological Molecule-Loaded Nanostructures Using Circular Dichroism and Fourier Transform Infrared Spectroscopy 7. Evaluation of Stimuli-Sensitive Nanoparticles in vitro 8. Analytical Techniques for Characterization of Nanodrugs 9. Cytotoxicity and Biological Compatibility 10. Cellular Uptake and Transcytosis 11. Evaluation of 3D Cell Culture Models for Efficacy Determination of Anticancer Nanotherapeutics 12. In vitro and in vivo Blood-Brain Barrier Models for the Evaluation of Drug Transport with Targeted Nanoparticles 13. Sterility Evaluation of Targeted Nanoparticles 14. Evaluation of Pharmacokinetics and Biodistribution of Targeted Nanoparticles 15. Evaluation of the in vivo Preclinical Toxicity of Targeted Nanoparticles 16. Transdermal Delivery of Targeted Nanoparticles and in vitro Evaluation 17. In vivo and in vitro Evaluation of Nose-to-Brain Delivery of Nanoparticles 18. Evaluation of Targeted Nanoparticles for Ocular Delivery 19. Vaginally Applied Nanocarriers and Their Characterizations 20. Oral Administration of Nanoparticles and Approaches for Design, Evaluation, and State of the Art 21. Drug Resistance Mechanisms and Strategies to Overcome Drug Resistance with Nanoparticulate Systems 22. Clinical Trials of Targeted Nanoparticulate Drug Delivery Systems 23. Evaluation of Targeted Mesoporous Silica Nanoparticles 24. Evaluation of Targeted Liposomes 25. Prospects of Nanomedicine with Nanocrystal Technology 26. Characteristics of Marketed Nanopharmaceutics 27. Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Delivery Systems;EPR Effect;Nanoparticulate Drug Delivery Systems;Dosage Forms;Drug Delivery Systems;Drug Active Substance;Sample Preparation;Drug Release;TRPS;PBPK Model;PLGA Nanoparticles;Liposomal Drug;Polymeric Micelles;CDE;Protein Corona;Nanoemulsion Gel;Receive FDA Approval;Vaginal Drug Delivery Systems;LAL Assay;Stimuli Responsive Drug Delivery Systems;Efflux Pump System;Ocular Bioavailability;Ocular Drug Delivery;HER2 Overexpressing Tumor Cell;ZP Measurement
1. Particle Size Determination of Targeted Nanoparticles 2. Zeta Potential Determination of Targeted Nanoparticles 3. Stability of Targeted Nanoparticles 4. Impact of PEGylation on Targeted Nanoparticulate Delivery 5. Ligands and Receptors for Targeted Delivery of Nanoparticles: Recent Updates and Challenges 6. Characterization of Biological Molecule-Loaded Nanostructures Using Circular Dichroism and Fourier Transform Infrared Spectroscopy 7. Evaluation of Stimuli-Sensitive Nanoparticles in vitro 8. Analytical Techniques for Characterization of Nanodrugs 9. Cytotoxicity and Biological Compatibility 10. Cellular Uptake and Transcytosis 11. Evaluation of 3D Cell Culture Models for Efficacy Determination of Anticancer Nanotherapeutics 12. In vitro and in vivo Blood-Brain Barrier Models for the Evaluation of Drug Transport with Targeted Nanoparticles 13. Sterility Evaluation of Targeted Nanoparticles 14. Evaluation of Pharmacokinetics and Biodistribution of Targeted Nanoparticles 15. Evaluation of the in vivo Preclinical Toxicity of Targeted Nanoparticles 16. Transdermal Delivery of Targeted Nanoparticles and in vitro Evaluation 17. In vivo and in vitro Evaluation of Nose-to-Brain Delivery of Nanoparticles 18. Evaluation of Targeted Nanoparticles for Ocular Delivery 19. Vaginally Applied Nanocarriers and Their Characterizations 20. Oral Administration of Nanoparticles and Approaches for Design, Evaluation, and State of the Art 21. Drug Resistance Mechanisms and Strategies to Overcome Drug Resistance with Nanoparticulate Systems 22. Clinical Trials of Targeted Nanoparticulate Drug Delivery Systems 23. Evaluation of Targeted Mesoporous Silica Nanoparticles 24. Evaluation of Targeted Liposomes 25. Prospects of Nanomedicine with Nanocrystal Technology 26. Characteristics of Marketed Nanopharmaceutics 27. Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Delivery Systems;EPR Effect;Nanoparticulate Drug Delivery Systems;Dosage Forms;Drug Delivery Systems;Drug Active Substance;Sample Preparation;Drug Release;TRPS;PBPK Model;PLGA Nanoparticles;Liposomal Drug;Polymeric Micelles;CDE;Protein Corona;Nanoemulsion Gel;Receive FDA Approval;Vaginal Drug Delivery Systems;LAL Assay;Stimuli Responsive Drug Delivery Systems;Efflux Pump System;Ocular Bioavailability;Ocular Drug Delivery;HER2 Overexpressing Tumor Cell;ZP Measurement
